Back
Editas Medicine Vs. AAR Industry Stock Comparison
Sell
1
EDIT
Editas Medicine
Last Price:
$1.04
Seasonality Move:
-1.48%
Sell
18
AIR
AAR
Last Price:
$50.12
Seasonality Move:
5.57%
Sell
1
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.03. The Score for EDIT is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.03The current trend is moderately bullish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
AIR Stock Price Chart
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 35.93 | Sell |
Chaikin Money Flow: | -2647223 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.17 - 1.69) | Sell |
Bollinger Bands (100): | (1.12 - 2.26) | Sell |
AIR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.13 | Sell |
Relative Strength Index (14 RSI): | 23.35 | Sell |
Chaikin Money Flow: | -101237 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.35 - 69.35) | Sell |
Bollinger Bands (100): | (61.64 - 69.74) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.18 | Sell |
20-day SMA: | 1.32 | Sell |
50-day SMA: | 1.48 | Sell |
200-day SMA: | 2.91 | Sell |
8-day EMA: | 1.1 | Sell |
20-day EMA: | 0.84 | Buy |
50-day EMA: | 0.47 | Buy |
200-day EMA: | 0.14 | Buy |
AIR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.48 | Sell |
20-day SMA: | 63.86 | Sell |
50-day SMA: | 65.45 | Sell |
200-day SMA: | 65.61 | Sell |
8-day EMA: | 57.27 | Sell |
20-day EMA: | 61.62 | Sell |
50-day EMA: | 64.1 | Sell |
200-day EMA: | 64.99 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
AAR Earnings Growth & AIR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.04 per share, an increase this year of $0.46 per share, and an increase next year of $0.73 per share.
Editas Medicine Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AAR Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |